RESUMO
OBJECTIVE: To evaluate the therapeutic potential of one-stage, full-mouth, ultrasonic debridement (FMUD) as a treatment for type 2 diabetic patients with generalized severe chronic periodontitis. METHOD AND MATERIALS: Sixteen patients diagnosed with generalized severe chronic periodontitis and type 2 diabetes mellitus were allocated to the diabetic group; another 15 subjects with periodontitis but without metabolic disorders were placed in the nondiabetic group. Both groups were treated using the FMUD protocol, a unique 45-minute session of ultrasonic debridement of all sites presenting periodontal disease. Patients were analyzed for the following parameters: plaque and bleeding indices, gingival recession, probing depth, and clinical attachment level. Further, diabetic subjects were assessed using fasting plasma glucose (FPG) and glycosylated hemoglobin (HbA1c) tests. Patients were evaluated at 3 and 6 months for all parameters. ANOVA and the Tukey test were used for data analysis (P < .05). RESULTS: Both groups showed improved periodontal health after treatment. There were no significant differences between the groups for any of the parameters assessed (P > .05). Diabetic subjects treated with FMUD had a clinical response similar to that of nondiabetic subjects at all pocket depths. No adverse effects or medical disturbances were observed in either group during treatment. FPG and HbA1c levels remained unaltered after treatment. CONCLUSION: Within the limitations of this study, FMUD promoted clinical improvements in patients with type 2 uncontrolled diabetes and generalized severe chronic periodontitis.
Assuntos
Periodontite Crônica/complicações , Periodontite Crônica/terapia , Diabetes Mellitus Tipo 2/complicações , Desbridamento Periodontal/métodos , Terapia por Ultrassom , Adulto , Idoso , Análise de Variância , Glicemia/análise , Periodontite Crônica/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Método Duplo-Cego , Feminino , Retração Gengival/complicações , Hemoglobinas Glicadas/análise , Humanos , Masculino , Pessoa de Meia-Idade , Índice Periodontal , Estatísticas não ParamétricasRESUMO
Aim: To determine the clinical changes occurred in chronic periodontitis patients presentinguncontrolled type 2 diabetes mellitus after a supragingival plaque control period. Methods:Subjects presenting generalized chronic periodontitis were divided into two groups: Non-diabetics(n=20) healthy subjects presenting chronic periodontitis; and Diabetics (n=14) subjects withuncontrolled type 2 diabetes mellitus presenting chronic periodontitis. All subjects went through 28days of supragingival plaque control - ST - (including prophylaxis, calculus removal, extractionof hopeless teeth and oral hygiene instructions) and were evaluated at baseline and after 28 daysby the following parameters: Full-Mouth Plaque Score (FMPS) and Full-Mouth Bleeding Scores(FMBS), Periodontal Probing Depth (PPD), Gingival Recession (GR) and Clinical AttachmentLevel (CAL). ANOVA/Tukeys test and Students t test were used for data analysis. Results: Nostatistically significant differences (p>0.05) between groups were observed at baseline for anyparameter. Both groups presented a significant reduction in FMPS and FMBS after 28 days(p<0.05), but no statistically significant difference was found (p>0.05) between groups. Clinically,only the Non-diabetic group showed a significant improvement after ST, in PPD of initially deeppockets (p<0.05). However, no change in the clinical parameters was observed in the diabeticsubjects (p>0.05). Conclusions: It may be concluded that uncontrolled diabetes mellitus reducesperiodontal changes in the supragingival plaque control regimen of subjects presenting withchronic periodontitis.
Assuntos
Periodontite Crônica , Placa Dentária , Diabetes MellitusRESUMO
BACKGROUND: This study evaluates the effect of triclosan/copolymer dentifrice on the 6-month clinical response of patients with generalized severe chronic periodontitis (GSCP) treated with one-stage, full-mouth ultrasonic debridement (FMUD). METHODS: Thirty patients diagnosed with GSCP (≥8 teeth presenting probing depth [PD] ≥5 mm and bleeding on probing [BOP]) were selected and randomly allocated to a control group (n = 15) subjected to FMUD and daily use of a placebo dentifrice or to a test group (n = 15) subjected to FMUD and daily use of a triclosan/copolymer dentifrice. Patients were analyzed for the following parameters: full-mouth plaque index (FMPI), full-mouth BOP score (FMBS), gingival recession, PD, and clinical attachment level (CAL). Patients were evaluated at 3 and 6 months by a calibrated and masked examiner. RESULTS: Initially, the groups presented similar periodontal conditions, with no significant differences in any of the parameters evaluated (P >0.05). In both groups, improvements in all periodontal parameters (P <0.05) were seen at the completion of the experimental period. Additionally, the test group showed lower FMPI (3 months) and FMBS (3 and 6 months) than the control group (P <0.05). Moreover, the CAL gain was significantly greater in the test group, especially at initially deep pockets (PD ≤7 mm). Whereas in the control group the CAL gain in deep pockets was 2.7 ± 0.6 mm, in the test group the CAL gain was 3.6 ± 1.4 mm (P <0.05). CONCLUSION: Within the limits of the present study, the use of triclosan/copolymer dentifrice promoted additional clinical benefits in the treatment of GSCP treated by one-stage FMUD.